Indian J Pharm Close
 

Table 2: Glycemic control and lipids of the patients with normal and abnormal liver function at baseline and after 3 months of rosiglitazone treatment

Table 2: Glycemic control and lipids of the patients with normal and abnormal liver function at baseline and after 3 months of rosiglitazone treatment